M. Debled

525 total citations
16 papers, 85 citations indexed

About

M. Debled is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, M. Debled has authored 16 papers receiving a total of 85 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in M. Debled's work include Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (5 papers) and Breast Cancer Treatment Studies (5 papers). M. Debled is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (5 papers) and Breast Cancer Treatment Studies (5 papers). M. Debled collaborates with scholars based in France, United States and Greece. M. Debled's co-authors include L. Mauriac, S. Giard, Gaëtan MacGrogan, G. Lorimier, J.M. Classe, Jean-­Marc Ferrero, A. Avril, Simone Mathoulin‐Pélissier, G. Le Bouëdec and Véronique Brouste and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

M. Debled

15 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Debled France 6 57 50 18 16 16 16 85
Francis Aitpillah Ghana 6 98 1.7× 58 1.2× 22 1.2× 14 0.9× 9 0.6× 10 139
A. Kohls Germany 6 74 1.3× 62 1.2× 9 0.5× 13 0.8× 11 0.7× 13 104
Leslie E. Oldfield Canada 5 49 0.9× 39 0.8× 10 0.6× 12 0.8× 11 0.7× 15 113
Curtis Olswold United States 3 54 0.9× 24 0.5× 24 1.3× 16 1.0× 14 0.9× 4 79
Nabeel Badri United States 5 50 0.9× 25 0.5× 10 0.6× 20 1.3× 8 0.5× 13 91
M Lenhard Germany 6 40 0.7× 23 0.5× 12 0.7× 6 0.4× 11 0.7× 16 103
Shingai B.A. Mutambirwa South Africa 6 16 0.3× 30 0.6× 22 1.2× 11 0.7× 8 0.5× 22 92
Rubens Rd United Kingdom 6 72 1.3× 51 1.0× 29 1.6× 13 0.8× 7 0.4× 9 127
Pooja Dharwadkar United States 4 69 1.2× 20 0.4× 27 1.5× 53 3.3× 3 0.2× 6 111
Marieke G. M. Braem Netherlands 4 55 1.0× 20 0.4× 30 1.7× 48 3.0× 13 0.8× 4 135

Countries citing papers authored by M. Debled

Since Specialization
Citations

This map shows the geographic impact of M. Debled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Debled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Debled more than expected).

Fields of papers citing papers by M. Debled

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Debled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Debled. The network helps show where M. Debled may publish in the future.

Co-authorship network of co-authors of M. Debled

This figure shows the co-authorship network connecting the top 25 collaborators of M. Debled. A scholar is included among the top collaborators of M. Debled based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Debled. M. Debled is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Earl, Helena, Louise Hiller, Julie Dunn, et al.. (2021). LBA11 Individual patient data meta-analysis of 5 non-inferiority RCTs of reduced duration single agent adjuvant trastuzumab in the treatment of HER2 positive early breast cancer. Annals of Oncology. 32. S1283–S1283. 14 indexed citations
2.
Tresch, Emmanuelle, Jean‐Sébastien Frenel, F. Lerebours, et al.. (2018). 5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study. European Journal of Cancer. 95. 30–37. 22 indexed citations
3.
Borgquist, Signe, Anita Giobbie‐Hurder, Thomas P. Ahern, et al.. (2016). Abstract PD1-03: Cholesterol, cholesterol lowering medication use, and breast cancer outcomes in the BIG 1-98 study. Cancer Research. 76(4_Supplement). PD1–3. 2 indexed citations
4.
Avril, A., G. Le Bouëdec, G. Lorimier, et al.. (2011). Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up. European Journal of Surgical Oncology. 37(7). 563–570. 16 indexed citations
5.
6.
Siedentopf, Friederike, Winfried Schoenegg, M. Kaufmann, M. Debled, & N. J. Robert. (2010). Efficacy of capecitabine (C)-based therapy in patients with first-line metastatic breast cancer (MBC) previously treated with adjuvant anthracyclines and taxanes.. Journal of Clinical Oncology. 28(15_suppl). 665–665. 1 indexed citations
7.
8.
MacGrogan, Gaëtan, Mickaël Guedj, Véronique Brouste, et al.. (2009). Genomic score predictive of metastatic evolution in breast cancer.. Cancer Research. 69(2_Supplement). 5069–5069. 1 indexed citations
9.
Debled, M., Nicolas Madranges, C. Mertens, et al.. (2008). Retrospective analysis of chemotherapy choices and overall survival according to treatment in 96 patients >75 years old with metastatic breast cancer. European Journal of Cancer Supplements. 6(7). 174–174. 5 indexed citations
10.
Debled, M., V. Girre, C. Mertens, et al.. (2008). Doxorubin-based adjuvant chemotherapy for elderly patients with hormone receptors negative breast carcinoma: a French geriatric oncology group (GERICO) phase II multicentric program. Critical Reviews in Oncology/Hematology. 68. S24–S25. 1 indexed citations
11.
Mauriac, L., Aparna Keshaviah, M. Debled, et al.. (2006). Predictors of early recurrence in postmenopausal women with hormone receptor positive breast cancer in the BIG 1-98 trial. European Journal of Cancer Supplements. 4(2). 111–111. 10 indexed citations
12.
MacGrogan, Gaëtan, I. de Mascarel, M. Debled, et al.. (2006). Prognostic value of Mib1 in a tissue microarray of 855 invasive breast carcinomas. European Journal of Cancer Supplements. 4(2). 123–124. 2 indexed citations
13.
Freyer, Gilles, M. Debled, J.-F. Geay, et al.. (2006). Celecoxib (Ce) + exemestane (Ex) versus placebo + Ex in post-menopausal (PM) metastatic breast cancer (MBC) patients (pts): A double-blind phase III GINECO study. Journal of Clinical Oncology. 24(18_suppl). 565–565. 5 indexed citations
14.
Mauriac, L., et al.. (2005). Compassionate use of fulvestrant: Experience from the Institut Bergonié. Journal of Clinical Oncology. 23(16_suppl). 746–746. 1 indexed citations
15.
Dujardin, F., et al.. (2000). [Primary intraosseous rhabdomyosarcoma].. PubMed. 86(3). 293–9. 1 indexed citations
16.
Debled, M., et al.. (1997). [Role of adjuvant chemotherapy in the treatment of soft tissue sarcoma].. PubMed. 84(6). 653–63. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis Aitpillah Breakdown of academic impact, for papers by A. Kohls Breakdown of academic impact, for papers by Leslie E. Oldfield Breakdown of academic impact, for papers by Curtis Olswold Breakdown of academic impact, for papers by Nabeel Badri Breakdown of academic impact, for papers by M Lenhard Breakdown of academic impact, for papers by Shingai B.A. Mutambirwa Breakdown of academic impact, for papers by Rubens Rd Breakdown of academic impact, for papers by Pooja Dharwadkar Breakdown of academic impact, for papers by Marieke G. M. Braem
Rankless by CCL
2026